This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior leaders from across the Pharmaceutical supply chain met at CPhI Worldwide 2019 to discuss how we build a future-fit workplace that ensures everybody has the opportunity to fulfil their full potential.
Much has been made of the potential of continuous platforms to supplant traditional pharmaceutical batch manufacturing and drive down API production costs. But how suitable is the technology to the precise requirements of complex pharma processing?
The rush to find effective vaccines against the coronavirus is only one part of the story. How is the pharmaceutical industry addressing the difficult issue of ensuring there will be enough manufacturing capacity to roll them out on a global scale?
Global Pharma Insights speaks to Stefan Schmidinger, Partner at Kemiex AG, on how its trade platform is bringing efficiency to a fragmented and regulated market and how traders of APIs are slowly embracing the digital revolution